Clinical trial
Visible Vessels do Not Predict Clinically Significant Bleeding After EMR - a Systematic Description of the Post EMR Defect
NCT03117400 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Visible Vessels do Not Predict Clinically Significant Bleeding After EMR - a Systematic Description of the Post EMR Defect
- Lead sponsor
- Western Sydney Local Health District
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 2, 2013
- Completion date
- March 30, 2017
- Enrollment
- 482 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
delayed bleeding post emr, endoscopic mucosal resection, large laterally spreading lesion in the colon